Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from ecancermedicalscience

02:19 EDT 23rd August 2017 | BioPortfolio

Here are the most relevant search results for "ecancermedicalscience" found in our extensive news archives from over 250 global news sources.

More Information about ecancermedicalscience on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about ecancermedicalscience for you to read. Along with our medical data and news we also list ecancermedicalscience Clinical Trials, which are updated daily. BioPortfolio also has a large database of ecancermedicalscience Companies for you to search.

Showing News Articles 1–25 of 4,500+ from ecancermedicalscience

Tuesday 22nd August 2017

Scientists uncover a deadly 'addiction' in oesophageal cancer

Scientists have discovered a new way of attacking oesophageal cancer cells that could make use of an existing drug in a new approach to treatment. Their study discovered a genetic weakness or 'Achilles' heel' in oesophageal cancer cells that makes them...

HPV vaccination rates lag for vulnerable population of childhood cancer survivors

Despite being at an increased risk for cancers associated with the human papillomavirus, the first comprehensive national survey found that HPV vaccination rates for childhood cancer survivors lag well behind the national average and that health care...

NSAIDs v opioids: pain, repurposing and prescription in a crisis

by ecancer reporter Will Davies, reviewed by Dr Gabriel Rodrigues Martins de Freitas, University of Caxias do Sul Pain is one of the earliest indicators of cancer, and chief among cancer patients’ fears. Yet, it has so far escaped a widely accepted...

Spaser can detect, kill circulating tumour cells to prevent cancer metastases, study finds

A nanolaser known as the spaser can serve as a super-bright, water-soluble, biocompatible probe capable of finding metastasised cancer cells in the blood stream and then killing these cells, according to a new research study. The study found the spaser...

Monday 21st August 2017

Zebrafish larvae could be used as 'avatars' to optimize personalised treatment of cancer

Portuguese scientists have for the first time shown that the larvae of a tiny fish could one day become the preferred model for predicting, in advance, the response of human malignant tumours to the various therapeutic drugs used to fight cancer. If the...

Education for healthcare professionals takes centre stage at ESMO Congress roundtable

The upcoming ESMO Congress in Madrid will host a roundtable on ‘Personalised Medicine: Translational Continuing Education Initiative’, organised by the Brussels-based European Alliance for Personalised Medicine (EAPM). The meeting at the Congress...

GIST tumours linked to NF1 mutations, genetic testing needed

Researchers at UC San Diego Moores Cancer Center, with colleagues from Memorial Sloan Kettering Cancer Center and Fox Chase Cancer Center, have determined that a specific region of the small bowel, called the duodenal-jejunal flexure or DJF, shows a high...

Friday 18th August 2017

New 'pathology atlas' maps genes in cancer to accelerate progress in personalised medicine

A new 'Pathology Atlas' is launched today with an analysis of all human genes in all major cancers showing the consequence of their corresponding protein levels for overall patient survival. The difference in expression patterns of individual cancers...

Lab tests show molecule appears to spur cell death in tumours

A drug-like molecule developed by Duke Health researchers appears to intercede in an inflammatory response that is at the centre of a variety of diseases, including some cancers, rheumatoid arthritis and Crohn's disease. The molecule, called Takinib,...

FDA approves inotuzumab ozogamicin for relapsed or refractory B-cell precursor ALL

The U.S. Food and Drug Administration approved inotuzumab ozogamicin for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL). The approval was based on data from INO-VATE ALL (NCT01564784), a...

FDA approves olaparib tablets for maintenance treatment in ovarian cancer

The U.S. Food and Drug Administration granted regular approval to olaparib tablets for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, who are in a complete or partial response...

Cell cycle-blocking drugs can shrink tumours by enlisting immune system in attack on cancer

In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs -- designed to halt cancer cell division -- do not just...

Thursday 17th August 2017

For post-menopausal women, vaginal oestrogens do not raise risk of cancer

Women who have gone through menopause and who have been using a vaginal form of oestrogen therapy do not have a higher risk of cardiovascular disease and cancer than women who have not been using any type of oestrogen. Among women with an intact uterus,...

Wednesday 16th August 2017

Scientists develop blood test that spots tumour-derived DNA in people with early-stage cancers

In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to accurately identify more than...

Noninvasive detection for early stage cancers from circulating DNA

A new DNA sequencing-based method could help non-invasively detect early stage cancers by analysing fragments of genetic material circulating in the blood that originate from tumours. The findings, published in Science Translational Medicine, may pave...

Impaired DNA replication can cause epigenetic changes inherited for several generations

Cell division is key for renewing the cells in our tissues and organs. There are two particular processes in which cell division is crucial: embryonic development and tumorigenesis. A fault in the process that copies DNA during cell division can cause...

PD-L1 immunotherapy linked to novel molecular partner

The majority of current cancer immunotherapies focus on PD-L1. This well studied protein turns out to be controlled by a partner, CMTM6, a previously unexplored molecule that is now suddenly also a potential therapeutic target. Researchers from the...

Tuesday 15th August 2017

Shared priorities and fears among women considering double mastectomy

A new study finds that more than half of women with early stage breast cancer considered an aggressive type of surgery to remove both breasts. The way women generally approach big decisions, combined with their values, impacts what breast cancer...

Prostate cancer biomarkers could improve precision therapy

Mayo Clinic researchers have identified a new cause of treatment resistance in prostate cancer. Their discovery also suggests ways to improve prostate cancer therapy. The findings appear in Nature Medicine. In the publication, the authors explain the...

Monday 14th August 2017

Bowel cancer deaths frop by a third in 20 years

The rate of people dying from bowel cancer in the UK has plummeted by more than 30 per cent in the last 20 years, according to new figures released today by Cancer Research UK. Bowel cancer was responsible for 38 deaths per 100,000 people in 1995,...

Cancer-fighting T cells are smarter, stronger than thought

Scientists studying the body's cancer-fighting T cells have a serious problem: When they culture them in the lab, the T cells sit around at equilibrium, waiting to bump into cancerous cells. But that's not how they operate inside the body, where they...

New cancer diagnosis may come with risk of thromboembolism

Patients newly diagnosed with cancer may have a substantially increased short-term risk of arterial thromboembolism, according to a study published today in the Journal of the American College of Cardiology. Patients with cancer face an increased risk of...

FDA expands ibrutinib indications to include chronic GVHD after SCT

the U.S. Food and Drug Administration approved ibrutinib for the treatment of adult patients with chronic graft versus host disease (cGVHD) after failure of one or more lines of systemic therapy. This is the first FDA-approved therapy for the treatment...

Rooting out genes behind glioblastoma onset and development

A Yale-led team of researchers has identified specific gene combinations that can cause deadly brain cancer glioblastoma, using new technology that can also pinpoint triggers of other types cancers, they report in the journal Nature...

Robots offer key advantages in oesophageal surgery

Based on what is believed to be the largest study of its kind, Allina Health researchers say robotic assisted transhiatal esophagectomy (RATE) is effective and safe for a carefully selected group of patients. Robotic technology gives surgeons a better...


Quick Search
Advertisement
 

News Quicklinks